| INTRODUCTION
Parkinson's disease (hereafter PD) is a progressive neurological disorder, of unknown aetiology, which currently affects 10 million people worldwide (Parkinson's Disease Foundation 2013; Pringsheim, Jette, Frolkis, & Steeves, 2014) . While a neurological and pharmacological approach to PD therapy concerned with motor symptomology can alleviate many of PD's symptoms, this treatment model also encourages an under-recognition and under-treatment of many of PDs most distressing experiences, leading to gaps between clinical priorities and patient need (Gibson, 2016) . This paper argues that the bio-psychosocial approaches developed within dementia care research can contribute much to PD's routine care [Downs, Clare, & Anderson, 2008; Spector & Orrell, 2010) . By adapting models of care used in dementia to PD, PD's routine care can better recognise the full range of patient's experiences as well as those prioritised within neurological approaches to PD therapy (Playfer, 2007) . After examining the medical models of PD and dementia and its critiques, this paper draws on a case study to explore how a bio-psycho-social model can be applied to PD, and the implications such an approach may have for PD's routine care.
| EXPLANATORY MODELS; PD AND DEMENTIA
The Psychiatrist and Anthropologist Arthur Kleinman's concept of explanatory models provides a means to conceptualise how illnesses are differentially defined, perceived and treated by practitioners, patients and society at large (Kleinman, 1988) . Although the predominant explanatory model for an illness offers a shared perspective through which an illness may be understood, how these models are interpreted differs significantly between clinicians and patients. Such differences lead to significant gaps between what clinicians identify as their priorities and patients own experiences (Downs, Clare, & Mackenzie, 2006) . Appreciating these differing explanatory models therefore provides clinicians with a means of better understanding their patient's experiences and how they may differ from their own perspectives. In doing so, Kleinman's original concept can assist clinicians in better identifying and addressing patient need.
Based on neurology, the most commonplace explanatory model for PD within medicine conceptualises the disease as the breakdown of striatal dopamine, manifested through the progressive development of motor symptomology and treated through dopaminergic and related therapies (Playfer, 2007) . This monodisciplinary model has been criticised for under-recognising and under-treating much of PD's symptomology (Gibson, 2016; Van Der Marck et al., 2009 ).
Greater attention is now being paid to PD's non-motor symptomology within routine care, inclusive of symptoms such as dementia (Aarsland, Zaccai, & Brayne, 2005) , mood disorders (Leentjens, 2004) , hallucinations (Gibson et al., 2013) , impulse control disorders (Wu, Politis, & Piccini, 2009) or the side effects of dopaminergic therapies (Matson, 2002) . Questions have also been raised regarding the relative impacts of PD's symptoms on quality of life, with research showing that PD patient's complaints diverge significantly when compared to those symptoms prioritised in PD's routine therapy (Tickle-Degnen & Doyle Lyons, 2004) . For example, while patients highlight mental, functional and psychosocial impairments as their biggest problems, clinicians routinely judge motor symptoms which respond to anti-Parkinson's drugs as most distressing (Abudi, Bar-Tal, Ziv, & Fish, 1997; Politis et al., 2010; Rahman, Griffin, Quinn, & Jahanshahi, 2008) . Although useful for identifying and addressing disease pathology, PD's conceptualisation within medicine therefore differs greatly when compared to patient's judgements about PD, leading to significant differences between clinical priorities and patients' lived experiences.
Rahman et al. argue for a paradigm shift in PD therapy, comprising a move away from a singular focus on motor symptoms towards a multidisciplinary, holistic approach which better reflects the complexity of the problems arising in PD (Rahman et al., 2008) . However, despite such an approach being previously recommended within national and international guidance regarding PD's routine treatment (Hellqvist & Bertero, 2015; Parkinson's UK 2012; 2015 Politis et al., 2010) . This suggests that a shift to more holistic and multidisciplinary models of care
has not yet taken place.
The explanatory model for dementia provides useful insights in relation regarding how such a paradigm shift in PD towards
What does this research add to existing knowledge in

Gerontology?
• This research shows how theoretical perspectives developed within dementia care research can usefully be applied to the care of people with Parkinson's disease.
• This research puts forward a bio-psycho-social approach to care for people living with Parkinson's disease.
What are the implications of this new knowledge for nursing care with older people?
• A biopsychosocial model of PD provides practitioners with a tool through which they can better identify and address the problems people living with PD routinely face.
• Parkinson's disease nurse specialists are well placed to deliver such a model, but require support to do so.
How could the findings be used to influence policy or practice or research or education?
• This model encourages research to recognise all aspects that PD has on the lives of people living with PD and encourages a research agenda which addresses their concerns.
• A biopsychosocial model of PD can support the design and development of holistic PD care services. multidisciplinary treatment and holistic care can be encouraged.
Historically, the lay model for dementia was "senility," in which memory losses were viewed as a natural and expected part of older age (Downs et al., 2006) . Only relatively recently has a neuropsychiatric model of dementia been developed, based on advances in neuroscience and medical imaging, which have led to some of the specific disease pathologies leading to dementia being identified (Downs et al., 2006; Fox, 1989) . The growth of this neuropsychiatric model, alongside political concerns about demographic ageing, has contributed to the recent dramatic growth in scientific and political concern being paid to dementia, demonstrated in the last decade by increasing international calls for research, such as the UK Prime Minister's challenge for dementia, and the French National Alzheimer Plan (Department of Health, 2012 (Dickinson et al., 2016) . Examples of such non-drug therapies include Cognitive Stimulation Therapy (Spector & Orrell, 2006 ; World Alzheimer Report 2011). The neuropsychiatric model of dementia has also been criticised for holding "an accompanying tendency to attribute the experience of persons with dementia exclusively to a disease process," thereby ignoring its psychological or social experience [Cotrell & Schulz, 1993: pp. 205 ]. Each of these issues can contribute to poor care practices, leading to calls for more holistic approaches to dementia care such as the UK Government's Living Well with Dementia strategy or UK Alzheimer's Society "Dementia Friends" initiative (Mitchell et al., 2016) .
The paucity of effective clinical treatments for dementia has arguably given space for alternative explanatory models for dementia to develop. Of greatest significance is the social model of dementia.
Exemplars of the social model include Sabat's concern over the self in dementia (Sabat & Harre, 1994 ) and Kitwood's (1997) seminal work on personhood in dementia. Key to the social model of dementia is the postulation that dementia is experienced through the "interplay of neurological impairment, physical health, sensory acuity, personality, biography and experience, relationships and social resources" (Kitwood, 1997) . The various problems associated with dementia, such as memory loss, confusion, agitation or wandering, are not simply the result of cognitive breakdown. They are also reflections of a person's shifting ability to make sense of the world. Not just biological change, it is what Kitwood (1997) famously termed "malignant social psychology," which "deprives a neurologically impaired individual of their 'personhood', or their socially determined right to exist in the world as individuals" that leads to many of the problems experienced in dementia. To successfully care for those with dementia, dementia care practitioners must therefore show a heightened sensitivity to the place people with dementia occupy in their individual social worlds. This model has also been critiqued, with subsequent developments moving towards a "rights" based approach to dementia, which calls for people with dementia to be accorded full rights as citizens, fully able to participate in life (Bartlett & O'Connor, 2010; World Health Organisation 2015) .
| DEMENTIA; A BIOPSYCHOSOCIAL MODEL
Expanding on the social model, recent work in dementia care research argues for a biopsychosocial approach to dementia (Sabat, 2008; Spector & Orrell, 2010) . This approach argues for a synthesis between medical and social models of illness and integrates the biological changes and physical, mental and emotional states occurring in dementia with the psychosocial impacts resulting from an individual's changing social environment. Spector and Orrell (2010) integrate the various biopsychosocial approaches in dementia into a single model (Figure 1 ), which they suggest can be used as a tool for understanding individual cases. This model encourages that dementia is recognised as "something which is malleable and where change, adaptation and improvement is possible" (Downs et al., 2008: p. 959 
| A BIO-PSYCHO-SOCIAL MODEL OF PD
Drawing upon Spector and Orrell (2010) alongside qualitative data from a study of men's experiences of living with PD (Gibson, 2016; Gibson & Kierans, 2016) , this paper puts forward a bio-psycho-social model for PD (Figure 2 ). The qualitative study examined 15 men's accounts of living with PD, the biological and psycho-social factors influencing their experience of PD, and their response to PD as it progressed. Findings from this study are reported elsewhere (Gibson, 2016; Gibson & Kierans, 2016) . Although experiences varied across individuals, several commonalities emerged which contributed to the development of this model. An initial onset of symptoms eventually led to patients seeking a diagnosis, when many men found their most taken for granted assumptions about life changing. With time, most could find ways to integrate the physical, psychological and social changes PD brought into their lives, drawing on a range of fixed and tractable biological and social factors (listed in Figure 2 ) when doing so.
After undergoing a period of disruption and adaptation early in their illness, most men adopted a circular and iterative approach to coping with PD. As their PD progressed, most men found that their coping strategies began to fail; for example, they could no longer manage long loved hobbies, while even everyday occupations eventually became too difficult for many to accomplish. But people found new ways to cope with these problems. Many involved medicine, for example increasing medication dosages or adding further medications to their regimes to address specific problems. Others were in men's individual social lives and included adapting how they completed their everyday activities, or changing how they interacted with other people (e.g. taking up less strenuous hobbies or pastimes). These issues each had consequences for men's everyday lives. By finding new ways to adapt to their illness and the problems it caused, several men could successfully cope with their PD. Importantly though, men continually had to adapt their responses to PD's worsening symptoms. This process of decline and adaptation could take place well into disability; however, as PD worsened, accomplishing these adaptations became more difficult, leaving people potentially vulnerable to both lower quality of life, declining mood and an exacerbation of their PD symptoms if they could no longer adapt to their PD.
At its core, adopting such a model in PD care encourages clinicians to consider PD's effects on the totality of those with PD's lives, and to identify interventions with can help people cope with all the problems they will face. By acknowledging this circular experience, medical and psycho-social interventions can be designed which are appropriate to people's individual illness stage and to their changing needs. At the biological or clinical level, such interventions include increasing PD medications or introducing new drug therapies. Interventions at a psychological or psychosocial level may be tailored to help people to cope with the onset of symptoms, to retain everyday occupations, or come to terms with their progressive losses in abilities as their PD worsens. In addition, the consequences of current interventions, such as the side effects resulting from increasing medication loads, can more easily be identified and managed. To explore the utility of adopting a bio-psycho-social approach in PD, this paper now turns its attention to "Tony," a man in middle age living with moderate PD.
| APPLYING A BIO-PSYCHO-SOCIAL APPROACH TO PD; THE CASE OF "TONY"
Tony (a pseudonym) was a 62-year-old man with moderate PD, who took part in the qualitative research described above. At the time of interview, Tony had been living with PD for 12 years. Tony also had
F I G U R E 1 A biopsychosocial model of dementia (Spector & Orrell 2010) (used with permission)
Psychosocial intervenƟons e.g. Tony took several PD drugs but noticed that they were becoming less effective, meaning his dosages had to be increased more and more frequently. Tony was also experiencing motor side effects, including "off periods," where his symptoms suddenly deteriorated at the end of a medication dose, and peak dose dyskinesia's or the involuntary movements associated with dopaminergic therapies (Matson, 2002) .
Consequently, Tony struggled more and more with his various daily activities; he did not know how much longer he would be able to drive, sail his fishing boat or walk his dogs on the beach near his home. Living in a rural and isolated area, Tony also struggled to drive to his local village to do his shopping, to see his GP, or get to the local PD clinic, 40 miles away. Tony was satisfied with his care team, but struggled to contact his local PD specialist nurse for advice or support when he needed it. Of greatest significance, the increases to his medication dosage, alongside more frequent side effects, meant Tony worried about how fast his condition was worsening, what would happen in the future and how much time he had left before his PD got "bad bad" (Gibson, 2016) . Also, given his history of depression, Tony particularly feared that his worsening PD could cause another bout of depression, leading him to consider suicide rather than live with both the severe disability and severe depression he feared his PD would bring.
Applying a bio-psycho-social model to Tony's care raises several implications for his PD care. For Tony, it was both declining activities of daily living and increases in medication side effects that posed a threat to his quality of life. Identifying what these impacts may be and whether therapies could assist Tony's continued social participation should therefore be investigated. Tony had also become very aware of the changes in bodily functioning caused by medications, planning his days around the times when his medications were functioning well. In addition to their beneficial effects, Tony also had to manage a whole range of side effects. Dyskinesia and "off" periods were both side effects of PD's therapy which Tony had to deal with on a daily basis. Tony had developed extensive knowledge of his medications and their effects over time, using this knowledge to understand and manage his illness.
While bringing benefits, new medications were also interpreted as a deterioration in his condition, leading Tony to worry about how much worse his condition might get. Decisions about medications should therefore be made in collaboration with the patient, paying attention not only to motor function, but also to how tolerable side effects may be. Furthermore, clinicians should investigate how medication usage is understood by patients, and how medication management influences this experience. In this respect, the biopsychosocial model shows up the need to take greater account of the "real-world" consequences of both PD's symptoms and PD therapy, and the need to involve patients in making informed decisions about their treatments.
Going beyond the pharmacological management of PD, a biopsychosocial model also gives important insights into the interrelatedness of PD symptoms, PD care and wider health and quality of life. PD should therefore not be treated in isolation, but should be understood within the context of a patient's wider health. Tony gave clear indications of his priorities for treatment. Given that Tony linked his depression and PD motor symptoms, importance should be paid to helping Tony manage his depression within the context of his PD. In addition, helping Tony manage and come to terms with his body's physical decline and the commensurate loss of hobbies, pastimes and other activities linked to a sense of self should also be priorities for his care. Such forms of support should reflect a concern for PD's effects within the context of Tony's life and lived experience.
In the case of Tony, pharmacological therapies can be complemented by psycho-social interventions such as physiotherapy, psychotherapy or occupational therapy, each at appropriate stages of his illness.
Psychotherapy can help manage expectations over bodily decline as well as mood disorders associated with PD (Brown et al., 2011) . In conjunction with medications, physiotherapy can assist with supporting physical movement (Tomlinson et al., 2013) . Occupational therapy services are well placed to assist with occupations; either through using assistive technologies, aids and adaptations, or simply in supporting people with PD to carry out daily tasks (Dixon et al., 2007; Foster, Bedekar, & TickleDegnen, 2014) . 
| CONCLUSION
A bio-psycho-social approach provides a means through which we can gain greater insights into PD's experience, which better reflect patient's needs. This model does, however, have several limitations. The empirical work used in the application of this model to PD is limited to a qualitative study of 15 men's experiences of PD.
This small and unrepresentative sample therefore limits its generalisability. Further refinement, which demonstrates the model's relevance among different patient groups, for example with women with PD or people of differing ages, is also necessary. The applicability of bio-psycho-social approaches drawn from dementia care to PD can also be questioned. Despite a significant degree of overlap in symptoms and age profiles, PD and dementia are separate illnesses with their own aetiologies, symptomologies, effects and courses.
While the structure of the model bears similarities, the actual processes or activities which drive PD's experiences will be different, as will be the solutions. There is also significant overlap between the factors identified in this model, with physical activities such as dance crossing over multiple fixed and tractable factors (McGill, Houston, & Lee, 2014; Spector & Orrell, 2010) . Although emerging from empirical research, this model has also not been tested empirically, so the factors which may contribute to well-being in PD may well be distinct compared to those listed in this model. Future research applying the model to nursing practice will help identify how such a model could best be implemented within routine care, alongside which factors are most relevant, and which may be most amenable to change.
Despite these limitations, the bio-psycho-social model of PD detailed above is one avenue through which Rahman et al.'s (2008) paradigm shift towards holistic PD care can be accomplished. It is important to note that this model does not seek to replace a biological and neurological model of PD; such a model remains the best structure through which future therapies for PD will be achieved.
However, the strength of adopting a bio-psycho-social approach to PD is that it encourages a greater appreciation of the psychological and social factors associated with the disease, which continue to be under-recognised within its care (McGill et al., 2014) . and emotional support to people with PD (Bhidayasiri et al., 2016; Theed, Eccles, Travers, & Simpson, 2016) . However, research suggests that excessive workloads and wider resource demands may threaten PD nurse specialist's ability to perform this role (Axelrod et al, 2010; Hellqvist & Bertero, 2015; Reynolds, Wilson-Barnett, & Richardson, 2010) . The continued expansion of PD nurse specialists should therefore be encouraged, but with sufficient allocation of resources to ensure that their roles can be delivered effectively.
The model described also contributes to the development of a theoretical and practical framework for the PD nurse specialist role. This model can also influence PD care pathways by providing a structure for when and how interventions should be offered. In relation to their biopsychosocial model of dementia, Spector and Orrell (2010: pp. 964) conclude by stating that their model "helps to work against (the assumption that the actions of a person are solely attributed to the illness) by taking a more individual and biopsychosocial perspective." In the context of PD, this model hopes to do the same.
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Implications for practice
• A biopsychosocial model of PD promotes a wider recognition of the environmental and social factors which affect people living with PD, and suggests ways in which health service interventions can be delivered.
• The above model illustrates how a person's needs may change as they move through the PD journey, and the dimensions in which they may need assistance and support.
• Parkinson's disease nurse specialists are well placed to deliver a biopsychosocial model of PD care, but need greater support in order to fulfil this role.
